Literature DB >> 26408917

"Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation.

Vladimir Y Bogdanov1, Henri H Versteeg2.   

Abstract

Tissue factor (TF), the main trigger of blood coagulation, is essential for normal hemostasis. Over the past 20 years, heightened intravascular levels and activity of TF have been increasingly perceived as an entity that significantly contributes to venous as well as arterial thrombosis. Various forms of the TF protein in the circulation have been described and proposed to be thrombogenic. Aside from cell and vessel wall-associated TF, several forms of non-cell-associated TF circulate in plasma and may serve as a causative factor in thrombosis. At the present time, no firm consensus exists regarding the extent, the vascular setting(s), and/or the mechanisms by which such TF forms contribute to thrombus initiation and propagation. Here, we summarize the existing paradigms and recent, sometimes paradigm-shifting findings elucidating the structural, mechanistic, and pathophysiological characteristics of plasma-borne TF. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26408917      PMCID: PMC4827326          DOI: 10.1055/s-0035-1556049

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  72 in total

Review 1.  An overview of mathematical modeling of thrombus formation under flow.

Authors:  Karin Leiderman; Aaron Fogelson
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

2.  Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus.

Authors:  Michaela Diamant; Rienk Nieuwland; Renée F Pablo; Augueste Sturk; Jan W A Smit; Jasper K Radder
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

Review 3.  Regulation of smooth muscle cell growth in injured artery.

Authors:  A W Clowes; M M Clowes; J Fingerle; M A Reidy
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

4.  Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.

Authors:  N S Key; A Slungaard; L Dandelet; S C Nelson; C Moertel; L A Styles; F A Kuypers; R R Bach
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

5.  Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer.

Authors:  Jian-Guo Wang; Julia E Geddings; Maria M Aleman; Jessica C Cardenas; Pichika Chantrathammachart; Julie C Williams; Daniel Kirchhofer; Vladimir Y Bogdanov; Ronald R Bach; Janusz Rak; Frank C Church; Alisa S Wolberg; Rafal Pawlinski; Nigel S Key; Jen Jen Yeh; Nigel Mackman
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

6.  Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.

Authors:  N A Prager; D R Abendschein; C R McKenzie; P R Eisenberg
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

7.  Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells.

Authors:  Andreas Eisenreich; Andreas Zakrzewicz; Kilian Huber; Hannes Thierbach; Wojciech Pepke; Petra Goldin-Lang; Heinz-Peter Schultheiss; Axel Pries; Ursula Rauch
Journal:  Oncol Rep       Date:  2013-04-22       Impact factor: 3.906

8.  Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.

Authors:  Caroline Lind; Linda E Flinterman; Kristin F Enga; Marianne T Severinsen; Søren R Kristensen; Sigrid K Braekkan; Ellisiv B Mathiesen; Inger Njølstad; Suzanne C Cannegieter; Kim Overvad; John-Bjarne Hansen
Journal:  Circulation       Date:  2013-11-22       Impact factor: 29.690

9.  Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?

Authors:  M Davila; L Robles-Carrillo; D Unruh; Q Huo; C Gardiner; I L Sargent; M Adam; B J Woodhams; J L Francis; V Y Bogdanov; A Amirkhosravi
Journal:  J Thromb Haemost       Date:  2014-02       Impact factor: 5.824

10.  A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation.

Authors:  Joseph A Jakubowski; Chunmei Zhou; Stipo Jurcevic; Kenneth J Winters; D Richard Lachno; Andrew L Frelinger; Neehar Gupta; Jo Howard; Christopher D Payne; Timothy G Mant
Journal:  Thromb Res       Date:  2013-12-07       Impact factor: 3.944

View more
  11 in total

Review 1.  The emerging roles of tumor-derived exosomes in hematological malignancies.

Authors:  M Boyiadzis; T L Whiteside
Journal:  Leukemia       Date:  2017-03-21       Impact factor: 11.528

Review 2.  Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Semin Thromb Hemost       Date:  2019-05-16       Impact factor: 4.180

3.  Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.

Authors:  B Ünlü; V Y Bogdanov; H H Versteeg
Journal:  Thromb Res       Date:  2017-05-25       Impact factor: 3.944

Review 4.  Why Do Patients Bleed?

Authors:  Jennifer Curnow; Leonardo Pasalic; Emmanuel J Favaloro
Journal:  Surg J (N Y)       Date:  2016-02-24

5.  Endothelial Cell-derived Extracellular Vesicles Size-dependently Exert Procoagulant Activity Detected by Thromboelastometry.

Authors:  Wolfgang Holnthoner; Cornelia Bonstingl; Carina Hromada; Severin Muehleder; Johannes Zipperle; Stefan Stojkovic; Heinz Redl; Johann Wojta; Herbert Schöchl; Johannes Grillari; Sylvia Weilner; Christoph J Schlimp
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

Review 6.  Beyond thrombosis: the impact of tissue factor signaling in cancer.

Authors:  Dusten Unruh; Craig Horbinski
Journal:  J Hematol Oncol       Date:  2020-07-14       Impact factor: 17.388

Review 7.  Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques.

Authors:  Yujiro Asada; Atsushi Yamashita; Yuichiro Sato; Kinta Hatakeyama
Journal:  Pathol Int       Date:  2020-03-13       Impact factor: 2.534

8.  A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy.

Authors:  Michelle K Becker-Hapak; Niraj Shrestha; Ethan McClain; Michael J Dee; Pallavi Chaturvedi; Gilles M Leclerc; Lynne I Marsala; Mark Foster; Timothy Schappe; Jennifer Tran; Sweta Desai; Carly C Neal; Patrick Pence; Pamela Wong; Julia A Wagner; David A Russler-Germain; Xiaoyun Zhu; Catherine M Spanoudis; Victor L Gallo; Christian A Echeverri; Laritza L Ramirez; Lijing You; Jack O Egan; Peter R Rhode; Jin-An Jiao; Gabriela J Muniz; Emily K Jeng; Caitlin A Prendes; Ryan P Sullivan; Melissa M Berrien-Elliott; Hing C Wong; Todd A Fehniger
Journal:  Cancer Immunol Res       Date:  2021-07-09       Impact factor: 11.151

9.  Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes.

Authors:  Ivelin I Ivanov; Bonita H R Apta; Arkadiusz M Bonna; Matthew T Harper
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

10.  Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.

Authors:  Julian Friebel; Eileen Moritz; Marco Witkowski; Kai Jakobs; Elisabeth Strässler; Andrea Dörner; Daniel Steffens; Marianna Puccini; Stella Lammel; Rainer Glauben; Franziska Nowak; Nicolle Kränkel; Arash Haghikia; Verena Moos; Heinz-Peter Schutheiss; Stephan B Felix; Ulf Landmesser; Bernhard H Rauch; Ursula Rauch
Journal:  Cells       Date:  2021-12-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.